Cervical polyp
WikiDoc Resources for Cervical polyp |
Articles |
---|
Most recent articles on Cervical polyp Most cited articles on Cervical polyp |
Media |
Powerpoint slides on Cervical polyp |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cervical polyp at Clinical Trials.gov Trial results on Cervical polyp Clinical Trials on Cervical polyp at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cervical polyp NICE Guidance on Cervical polyp
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cervical polyp Discussion groups on Cervical polyp Patient Handouts on Cervical polyp Directions to Hospitals Treating Cervical polyp Risk calculators and risk factors for Cervical polyp
|
Healthcare Provider Resources |
Causes & Risk Factors for Cervical polyp |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2] Aditya Ganti M.B.B.S. [3]
Synonyms and keywords: Polypoid cervical lesion; Cervical polypoid lesion; Polypoid cervical growth
Overview
Cervical polyps are defined as polypoid benign overgrowths of endocervical tissue. Usually, cervical polyps are growths projecting into the cervical canal. Cervical polyps are the most common cause of intermenstrual vaginal bleeding.There are no established causes for cervical polyps. They can be classified according to their morphological features such as: distribution, shape, size, and the presence of a pedicle. The pathogenesis of cervical polyp is characterized by chronic inflammation of the endocervical canal. Typically, cervical polyps arise from the endocervical canal and tend to protrude into the external cervix. The estimated prevalence of cervical polyps is approximately 1.5–10% in the general population. Common risk factors of the development of cervical polyps, include: chronic inflammation, hormonal factors, presence of endometrial hyperplasia, and previous history of pregnancy. Cervical polyps are more commonly observed among perimenopausal and postmenopausal women. Early clinical features may include abnormal vaginal bleeding, postcoital vaginal bleeding, and abnormal vaginal discharge. The diagnosis of a cervical polyp is made with a cervical biopsy, findings may include: inflamed and dilated endocervical (mucus) glands and myxoid stroma. Ring forceps in conjunction with biopsy is the most common approach for the treatment of cervical polyps.
Historical Perspective
Cervical polyps were first described by Peterson and Novak in 1956 following the description of endometrial polyps.[1][2]
Classification
Based on polyp location, cervical polyps can be classified into two types:
- Ectocervical polyps
- Develop from the outer surface layer cells of the cervix.
- More commonly seen in postmenopausal women.
- Endocervical polyps
- Develop from cervical glands inside the cervical canal.
- The majority of cervical polyps are endocervical polyps.
- More commonly seen in premenopausal women.
Pathophysiology
Anatomy
- The normal cervix is fusiform in shape, with the narrowest portions at the internal and external os. It measures 3 to 5 cm in length and 2 to 3 cm in diameter.
- The portio vaginalis, is the visible portion of the cervix that protrudes into the vagina and is surrounded by a reflection of the vaginal wall on each side termed the anterior, posterior, and lateral fornix.
- The supravaginal cervix is the intra-abdominal portion of the cervix that lies above the point of attachment of the vaginal vault
- The peritoneum posterior to the supravaginal cervix forms the lining of the posterior cul-de-sac (pouch of Douglas).
- The external cervical os is small, round, and centrally placed in nulliparous women.
- In parous women who have labored into the third stage, it is more likely to be a patulous, transverse slit.
- The internal cervical os is normally less than 3 mm in diameter in nonpregnant women, even if parous .
- In the sagittal axis, the cervix lies between the bladder and rectum.
- The cervix is supported by the uterosacral ligaments, which surround the cervix and vagina and extend laterally and posteriorly toward the second to fourth sacral vertebra, and the cardinal ligaments, which are fibromuscular bands that fan out laterally from the lower uterine segment and cervix to the lateral pelvic walls.
Blood Supply
- The blood supply comes from a descending branch of the uterine artery.
- The lymphatic drainage is to the parametrial nodes, then to the obturator, internal iliac, and external iliac nodes with secondary drainage to the presacral, common iliac, and para-aortic lymph nodes.
Nerve Supply
- The nerve supply is autonomic (sympathetic and parasympathetic).
- The nerves enter the upper cervix on either side and form two lateral semicircular plexuses, called Frankenhäuser plexus, a terminal part of the presacral plexus.
Pathogenesis
- The pathogenesis of cervical polyp is characterized by chronic inflammation of the endocervical canal.
- The exact mechanism of cervical polyps origin is not clearly understood. However, cervical polyps are believed to occur due to:
- An abnormal response to increased levels of estrogen
- Chronic inflammation
- Clogged blood vessels in the cervix
- Cervical polyps arise from the endocervical canal and tend to protrude in the external cervix.
- There are no genes associated with the development of cervical polyp.
- On gross pathology, flesh-colored, single finger-like growth, 1 cm size, are characteristic findings of cervical polyp.
- On microscopic histopathological analysis, inflamed and dilated endocervical (mucus) glands and myxoid stroma are characteristic findings of cervical polyp.
Causes
There are no established causes for cervical polyps.[2]
Differentiating Cervical Polyp from other Diseases
Cervical polyp must be differentiated from other diseases that cause abnormal vaginal bleeding, dyspareunia, and abnormal vaginal discharge
- Cervical intraepithelial neoplasia
- Cervicitis
- Benign endometrial polyp
- Fibroepithelial stromal polyp
- Adenosarcoma
- Cervical cancer
Abnormal Uterine bleeidng differential diagnosis | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ob-Gyn neoplasm and diseases | Clinical manifestations | Para-clinical findings | Gold standard | ||||||||||||||
Symptoms | Physical exam | Lab Findings | Imaging | Histopathology | |||||||||||||
Abnormal
vaginal bleeding |
Other Genitourinary/ Gastrointestinal symptoms | Abdominal pain | Pelvic
pain |
B symptoms | Gynecological examinations | Abdominal
mass |
HPV
Pap smear STI panel |
Other labs | Ultrasound | Other
imagings | |||||||
Cervical polyp[3] |
|
− | − | − |
|
− | − |
|
|
|
|||||||
Cervical cancer[4][5][6][7][8][9][10][11] |
|
|
+ | + | + |
|
+ | ± HPV |
|
|
T2-weighted MRI :
|
Cervical intraepithelial neoplasia:
|
|||||
Cervical leiomyoma[12][13][14][15][16][17][18][19][20] |
|
|
+ | + | − |
|
±
|
− |
|
T2-weighted MRI:
enhancement
|
|
| |||||
Cervical lymphoma[21][22][23] |
|
+ | + | + |
|
+ | Pap smear: | Immunohistochemistry markers: |
|
MRI:
|
|
| |||||
Cervical sarcoma[24][25][26][27] |
|
|
+ | + | ± |
|
+ | − | Leiomyosarcoma markers: |
|
MRI:
|
|
|||||
Cervical erosion(Ectropion)[28][29][30][31][32] |
|
|
+ | + | − |
|
− | − | N/A | N/A | N/A |
|
|
||||
Cervicitis[33][34][35][36][37] |
|
|
+ | + |
|
|
− | STI panel: |
|
MRI:
May be detected as retention cysts in cervix. |
|
||||||
Adenemyosis[38][39][40][41][42][43] |
|
|
+ | + | − |
|
|
− |
|
|
MRI:
|
|
| ||||
Cervical ectopic pregnancy[44][45] |
|
+ | − | − |
|
± | − |
|
|
T2-weighted MRI:
T1-weighted MRI:
|
|
| |||||
Nabothian cyst[46][47][48][49] |
|
|
|
− | − |
|
− | − | N/A |
|
T1-weighted
|
|
|
Epidemiology and Demographics
The estimated prevalence of cervical polyps is approximately 1.5–10% in the general population.[2]
Age
- Cervical polyps are more commonly observed among patients aged 40 to 55 years old.
- Cervical polyps are more commonly observed among perimenopausal and postmenopausal women.[2]
Race
- There is no racial predilection for cervical polyps.[2]
Risk Factors
Common risk factors in the development of cervical polyps include:[2]
- Chronic inflammation
- Hormonal factors
- Presence of endometrial hyperplasia
- Previous history of pregnancy
Natural History, Complications and Prognosis
- The majority of patients with cervical polyps remain asymptomatic for years.
- Early clinical features may include abnormal vaginal bleeding, postcoital vaginal bleeding, and abnormal vaginal discharge.
- If left untreated, only 0.2–1.7% of the patients with cervical polyps may progress to develop malignant transformation.
- Common complications of cervical polyps include malignant transformation, bleeding, and recurrence.
- The prognosis is generally excellent, and the 5-survival rate is approximately 100%.
Diagnosis
Diagnostic Criteria
The diagnosis of cervical polyp is made with a cervical biopsy. Characteristic findings in a biopsy of a cervical polyp include:[2]
- Squamous metaplasia
- Inflammatory cells
Symptoms
- Cervical polyp is usually asymptomatic.[2]
- Symptoms of cervical polyp may include the following:
- Intermenstrual bleeding (most common)
- Vaginal discharge
- Dyspareunia
- Postcoital bleeding
- Dysmenorrhea
- Leukorrhea
Physical Examination
- Patients with cervical polyps are usually well-appearing.
- Digital examination findings of the cervix, may include:[2]
- Sessile or broad-based finger-like growth
Laboratory Findings
There are no specific laboratory findings associated with cervical polyps.
Imaging Findings
- Ultrasound is the imaging modality of choice for cervical polyp.
- On ultrasound, cervical polyp is characterized by the following findings:[2][50]
- Sessile or pedunculated well-circumscribed masses within the endocervical canal
- May be hypoechoic or echogenic
- Identifying the stalk attaching to the cervical wall helps differentiate it from an endometrial polyp
- The image below shows a cervical polyp characterized as a well-circumscribed mass within the endocervical canal.
Other Diagnostic Studies
- Cervical polyp may also be diagnosed with colposcopy.
- Findings on colposcopy may include:
- Protruding polypoid mass
- Smooth, red or purple, fingerlike growths on the cervix
- Cervical bleeding
- Cervical friableness
- A cervical biopsy will most often show cells that are consistent with a benign polyp.
Treatment
Medical Therapy
- There is no medical treatment for cervical polyp; the mainstay of therapy is surgical excision.[2]
- Response to surgery can be monitored with regular ultrasound screenings every 6 or 12 months.
- If the polyp is infected, an antibiotic may be prescribed.
Surgery
- Surgery is the mainstay of therapy for cervical polyp.
- Ring forceps in conjunction with biopsy is the most common approach to the treatment of cervical polyp.
- Surgical string may also be performed for patients with a cervical polyp.
- Other therapies, include: laser or cauterization.
Prevention
- Effective measures for the primary prevention of cervical polyp include periodic ultrasound and cervical screening.[2]
- Once diagnosed and successfully treated, patients with cervical polyp are followed-up every 6 or 12 months.
- Follow-up testing includes pelvic examination, vaginal ultrasound, and colposcopy.
References
- ↑ Peterson WF, Novak ER. Endometrial polyps. Obstet Gynecol. 1956; 8:40–49.
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 Golan A, Ber A, Wolman I, David MP (1994). "Cervical polyp: evaluation of current treatment". Gynecol. Obstet. Invest. 37 (1): 56–8. PMID 8125411.
- ↑ Mitchell H (May 2004). "Vaginal discharge--causes, diagnosis, and treatment". BMJ. 328 (7451): 1306–8. doi:10.1136/bmj.328.7451.1306. PMC 420177. PMID 15166070.
- ↑ Hippisley-Cox J, Coupland C (January 2013). "Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm". Br J Gen Pract. 63 (606): e11–21. doi:10.3399/bjgp13X660733. PMC 3529288. PMID 23336450.
- ↑ Dunyo, Priscilla; Effah, Kofi; Udofia, Emilia Asuquo (2018). "Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study". BMC Public Health. 18 (1). doi:10.1186/s12889-018-6065-6. ISSN 1471-2458.
- ↑ Khalife D, El Housheimi A, Khalil A, Saba C S, Seoud M, Rammal R, Abdallah IE, Abdallah R (February 2019). "Treatment of cervical cancer metastatic to the abdominal wall with reconstruction using a composite myocutaneous flap: A case report". Gynecol Oncol Rep. 27: 38–41. doi:10.1016/j.gore.2018.12.006. PMC 6302027. PMID 30603660. Vancouver style error: name (help)
- ↑ . doi:10.1097/PAS.0000000000000498. Check
|doi=
value (help). Missing or empty|title=
(help) - ↑ Brenner PF (September 1996). "Differential diagnosis of abnormal uterine bleeding". Am. J. Obstet. Gynecol. 175 (3 Pt 2): 766–9. PMID 8828559.
- ↑ Alcázar, Juan Luis; Arribas, Sara; Mínguez, José Angel; Jurado, Matías (2014). "The Role of Ultrasound in the Assessment of Uterine Cervical Cancer". The Journal of Obstetrics and Gynecology of India. 64 (5): 311–316. doi:10.1007/s13224-014-0622-4. ISSN 0971-9202.
- ↑ Qing L, Xiang T, Guofu Z, Weiwei F (September 2014). "Leukemoid reaction in cervical cancer: a case report and review of the literature". BMC Cancer. 14: 670. doi:10.1186/1471-2407-14-670. PMC 4174654. PMID 25223869.
- ↑ Qing L, Xiang T, Guofu Z, Weiwei F (September 2014). "Leukemoid reaction in cervical cancer: a case report and review of the literature". BMC Cancer. 14: 670. doi:10.1186/1471-2407-14-670. PMC 4174654. PMID 25223869.
- ↑ Al-Habib A, Elgamal EA, Aldhahri S, Alokaili R, AlShamrani R, Abobotain A, AlRaddadi K, Alkhalidi H (November 2016). "Large primary leiomyoma causing progressive cervical deformity". J Surg Case Rep. 2016 (11). doi:10.1093/jscr/rjw190. PMC 5159177. PMID 27887011.
- ↑ Adaikkalam J (April 2016). "Lipoleiomyoma of Cervix". J Clin Diagn Res. 10 (4): EJ01–2. doi:10.7860/JCDR/2016/16505.7531. PMID 27190823.
- ↑ Houser, L. Murray; Carrasco, C. H.; Sheehan, C. R. (1979). "Lipomatous tumour of the uterus: radiographic and ultrasonic appearance". The British Journal of Radiology. 52 (624): 992–993. doi:10.1259/0007-1285-52-624-992. ISSN 0007-1285.
- ↑ Keriakos, Remon; Maher, Mark (2013). "Management of Cervical Fibroid during the Reproductive Period". Case Reports in Obstetrics and Gynecology. 2013: 1–3. doi:10.1155/2013/984030. ISSN 2090-6684.
- ↑ Coronado GD, Marshall LM, Schwartz SM (May 2000). "Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study". Obstet Gynecol. 95 (5): 764–9. PMID 10775744.
- ↑ Kamra, Hemlata T (2013). "Myxoid Leiomyoma of Cervix". JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. doi:10.7860/JCDR/2013/6171.3805. ISSN 2249-782X.
- ↑ El-agwany, Ahmed Samy (2015). "Lipoleiomyoma of the uterine cervix: An unusual variant of uterine leiomyoma". The Egyptian Journal of Radiology and Nuclear Medicine. 46 (1): 211–213. doi:10.1016/j.ejrnm.2014.10.001. ISSN 0378-603X.
- ↑ Chaparala RP, Fawole AS, Ambrose NS, Chapman AH (March 2004). "Large bowel obstruction due to a benign uterine leiomyoma". Gut. 53 (3): 386, 430. PMC 1773948. PMID 14960521.
- ↑ Yokoyama Y, Shinohara A, Hirokawa M, Maeda N (2003). "Erythrocytosis due to an erythropoietin-producing large uterine leiomyoma". Gynecol. Obstet. Invest. 56 (4): 179–83. doi:10.1159/000074104. PMID 14564105.
- ↑ Grace A, O'Connell N, Byrne P, Prendiville W, O'Donnell R, Royston D, Walsh CB, Leader M, Kay E (1999). "Malignant lymphoma of the cervix. An unusual presentation and a rare disease". Eur. J. Gynaecol. Oncol. 20 (1): 26–8. PMID 10422676.
- ↑ Kanaan, Daniel; Parente, Daniella Braz; Constantino, Carolina Pesce Lamas; Souza, Rodrigo Canellas de (2012). "Linfoma de colo de útero: achados na ressonância magnética". Radiologia Brasileira. 45 (3): 167–169. doi:10.1590/S0100-39842012000300009. ISSN 0100-3984.
- ↑ Frey NV, Svoboda J, Andreadis C, Tsai DE, Schuster SJ, Elstrom R, Rubin SC, Nasta SD (September 2006). "Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literature". Leuk. Lymphoma. 47 (9): 1894–901. doi:10.1080/10428190600687653. PMID 17065003.
- ↑ Wright JD, Rosenblum K, Huettner PC, Mutch DG, Rader JS, Powell MA, Gibb RK (November 2005). "Cervical sarcomas: an analysis of incidence and outcome". Gynecol. Oncol. 99 (2): 348–51. doi:10.1016/j.ygyno.2005.06.021. PMID 16051326.
- ↑ Khosla, Divya; Gupta, Ruchi; Srinivasan, Radhika; Patel, Firuza D.; Rajwanshi, Arvind (2012). "Sarcomas of Uterine Cervix". International Journal of Gynecological Cancer. 22 (6): 1026–1030. doi:10.1097/IGC.0b013e31825a97f6. ISSN 1048-891X.
- ↑ Miccò M, Sala E, Lakhman Y, Hricak H, Vargas HA (December 2015). "Imaging Features of Uncommon Gynecologic Cancers". AJR Am J Roentgenol. 205 (6): 1346–59. doi:10.2214/AJR.14.12695. PMC 5502476. PMID 26587944.
- ↑ . doi:10.1097/IGC.0b013e31825a97f6. Check
|doi=
value (help). Missing or empty|title=
(help) - ↑ Mitchell L, King M, Brillhart H, Goldstein A (September 2017). "Cervical Ectropion May Be a Cause of Desquamative Inflammatory Vaginitis". Sex Med. 5 (3): e212–e214. doi:10.1016/j.esxm.2017.03.001. PMC 5562466. PMID 28460993.
- ↑ Mitchell H (May 2004). "Vaginal discharge--causes, diagnosis, and treatment". BMJ. 328 (7451): 1306–8. doi:10.1136/bmj.328.7451.1306. PMC 420177. PMID 15166070.
- ↑ Sharma, Abhishek; Ojha, Ranapratap; Sengupta, Parama; Chattopadhyay, Sarbani; Mondal, Soumit (2013). "Cervical intramural pregnancy: Report of a rare case". Nigerian Medical Journal. 54 (4): 271. doi:10.4103/0300-1652.119670. ISSN 0300-1652.
- ↑ . doi:10.12865/CHSJ.42.02.11. Missing or empty
|title=
(help) - ↑ Casey PM, Long ME, Marnach ML (February 2011). "Abnormal cervical appearance: what to do, when to worry?". Mayo Clin. Proc. 86 (2): 147–50, quiz 151. doi:10.4065/mcp.2010.0512. PMC 3031439. PMID 21270291.
- ↑ Mattson SK, Polk JP, Nyirjesy P (July 2016). "Chronic Cervicitis: Presenting Features and Response to Therapy". J Low Genit Tract Dis. 20 (3): e30–3. doi:10.1097/LGT.0000000000000225. PMID 27243142.
- ↑ Rosenfeld WD, Clark J (June 1989). "Vulvovaginitis and cervicitis". Pediatr. Clin. North Am. 36 (3): 489–511. PMID 2660084.
- ↑ Meyer T (August 2016). "Diagnostic Procedures to Detect Chlamydia trachomatis Infections". Microorganisms. 4 (3). doi:10.3390/microorganisms4030025. PMID 27681919.
- ↑ Woods, Jennifer L.; Bailey, Sarabeth L.; Hensel, Devon J.; Scurlock, Amy M. (2011). "Cervicitis in Adolescents: Do Clinicians Understand Diagnosis and Treatment?". Journal of Pediatric and Adolescent Gynecology. 24 (6): 359–364. doi:10.1016/j.jpag.2011.06.006. ISSN 1083-3188.
- ↑ Jayakumar, Naveen Kumar Bhagavathula (2015). "Cervicitis: How Often Is It Non-specific!". JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. doi:10.7860/JCDR/2015/11594.5673. ISSN 2249-782X.
- ↑ Filip G, Balzano A, Cagnacci A (November 2018). "Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance". Minerva Ginecol. doi:10.23736/S0026-4784.18.04291-0. PMID 30486633.
- ↑ Fujino T, Watanabe T, Shinmura R, Hahn L, Nagata Y, Hasui K (December 1992). "Acute abdomen due to adenomyosis of the uterus: a case report". Asia Oceania J Obstet Gynaecol. 18 (4): 333–7. PMID 1492806.
- ↑ Fujino T, Watanabe T, Shinmura R, Hahn L, Nagata Y, Hasui K (December 1992). "Acute abdomen due to adenomyosis of the uterus: a case report". Asia Oceania J Obstet Gynaecol. 18 (4): 333–7. PMID 1492806.
- ↑ Zhou Y, Wu B, Li H (October 1996). "[The value of serum CA125 assays in the diagnosis of uterine adenomyosis]". Zhonghua Fu Chan Ke Za Zhi (in Chinese). 31 (10): 590–3. PMID 9275451.
- ↑ Tamai, Ken; Togashi, Kaori; Ito, Tsuyoshi; Morisawa, Nobuko; Fujiwara, Toshitaka; Koyama, Takashi (2005). "MR Imaging Findings of Adenomyosis: Correlation with Histopathologic Features and Diagnostic Pitfalls". RadioGraphics. 25 (1): 21–40. doi:10.1148/rg.251045060. ISSN 0271-5333.
- ↑ Dartmouth, Katherine (2014). "A systematic review with meta-analysis: the common sonographic characteristics of adenomyosis". Ultrasound. 22 (3): 148–157. doi:10.1177/1742271X14528837. ISSN 1742-271X.
- ↑ Mouhajer M, Obed S, Okpala AM (June 2017). "Cervical Ectopic Pregnancy in Resource Deprived Areas: A Rare and Difficult Diagnosis". Ghana Med J. 51 (2): 94–97. PMC 5611908. PMID 28955106.
- ↑ Rathod, Setu; Samal, SunilKumar (2015). "Cervical ectopic pregnancy". Journal of Natural Science, Biology and Medicine. 6 (1): 257. doi:10.4103/0976-9668.149221. ISSN 0976-9668.
- ↑ Casey PM, Long ME, Marnach ML (February 2011). "Abnormal cervical appearance: what to do, when to worry?". Mayo Clin. Proc. 86 (2): 147–50, quiz 151. doi:10.4065/mcp.2010.0512. PMC 3031439. PMID 21270291.
- ↑ Bin Park, Sung; Lee, Jong Hwa; Lee, Young Ho; Song, Mi Jin; Choi, Hye Jeong (2010). "Multilocular Cystic Lesions in the Uterine Cervix: Broad Spectrum of Imaging Features and Pathologic Correlation". American Journal of Roentgenology. 195 (2): 517–523. doi:10.2214/AJR.09.3619. ISSN 0361-803X.
- ↑ Torky, Haitham A. (2016). "Huge Nabothian cyst causing Hematometra (case report)". European Journal of Obstetrics & Gynecology and Reproductive Biology. 207: 238–240. doi:10.1016/j.ejogrb.2016.10.042. ISSN 0301-2115.
- ↑ Okamoto, Yoshikazu; Tanaka, Yumiko O.; Nishida, Masato; Tsunoda, Hajime; Yoshikawa, Hiroyuki; Itai, Yuji (2003). "MR Imaging of the Uterine Cervix: Imaging-Pathologic Correlation". RadioGraphics. 23 (2): 425–445. doi:10.1148/rg.232025065. ISSN 0271-5333.
- ↑ Cervical polyp. Dr. Henry Kenipe. Radiopedia. http://radiopaedia.org/articles/cervical-polyp Accessed on March 31,2016